Trans1 sees IPO of 5.5 mln shares at $12-$14 each
Sept 28 (Reuters) - Trans1 Inc, a medical device company, on Friday filed for an initial public offering of 5.5 million shares at an estimated price of $12 to $14 per share.
Lehman Brothers Inc, Piper Jaffray & Co, Cowen and Co LLC and Wachovia Capital Markets LLC are underwriting the IPO, the company said in an amended filing with the U.S. Securities and Exchange Commission.
The Wilmington, North Carolina-based company said it applied for a Nasdaq listing under the symbol "TSON." (Reporting by Avishek Mishra in Bangalore)